Factors Influencing Dosage Adjustments: Things like other health conditions, how well the body absorbs B12, and any side effects can affect the need for dosage changes
Results Increased expression of antioxidant enzymes in mice that overexpress human -synuclein Using two existing transgenic mouse lines, we produced a new mouse, SARE, which overexpresses human -synuclein under the direction of the TH promoter and is capable of reporting an antioxidant response via expression of human placental alkaline phosphatase (hPLAP)
Notably, that MEC-1 cells had higher basal level of ECAR compared to HG-3 cell line, which may contribute to their lower sensitivity to OXPHOS inhibition ( Figure 2B )
Longer term For longer protocols, review broad health trends every 3-6 months with a clinician
The observation that higher plasma concentrations of 2 can be achieved after oral delivery than for PZQ, coupled with the greater ex vivo potency of compound 2 , strongly suggest that further optimization will yield an orally bioavailable schistosomicidal agent that will be transformative in the clinical setting
